MHRA response to Brexit

Following the outcome of the EU referendum, the Medicines and Healthcare products Regulatory Agency (MHRA) is working closely with the Government to analyse the best options and opportunities available for the safe and effective regulation of medicines and medical devices in the UK.

While negotiations continue, the UK remains a full and active member of the EU, with all the rights and obligations of EU membership firmly in place.

The MHRA has responded to the outcome of the EU referendum in relation to:

  • Medicines regulation
  • Devices regulation
  • Vigilance and market surveillance

Read their response here.

Tagged with

Published on 11. August 2016 in News UK